TY - JOUR
T1 - Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
AU - Gao, Caifang
AU - Liu, Lijuan
AU - Zhou, Yangyang
AU - Bian, Zhaoxiang
AU - Wang, Shengpeng
AU - Wang, Yitao
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/6/17
Y1 - 2019/6/17
N2 - Inflammatory bowel disease (IBD) is an idiopathic intestinal inflammatory disease that comprises ulcerative colitis (UC) and Crohn's disease (CD). IBD involves the ileum, rectum, and colon, and common clinical manifestations of IBD are diarrhea, abdominal pain, and even bloody stools. Currently, non-steroidal anti-inflammatory drugs, glucocorticoids, and immunosuppressive agents are used for the treatment of IBD, while their clinical application is severely limited due to unwanted side effects. Chinese medicine (CM) is appealing more and more attention and investigation for the treatment of IBD owing to the potent anti-inflammation pharmacological efficacy and high acceptance by patients. In recent years, novel drug delivery systems are introduced apace to encapsulate CM and many CM-derived active constituents in order to improve solubility, stability and targeting ability. In this review, advanced drug delivery systems developed in the past and present to deliver CM for the treatment of IBD are summarized and future directions are discussed.
AB - Inflammatory bowel disease (IBD) is an idiopathic intestinal inflammatory disease that comprises ulcerative colitis (UC) and Crohn's disease (CD). IBD involves the ileum, rectum, and colon, and common clinical manifestations of IBD are diarrhea, abdominal pain, and even bloody stools. Currently, non-steroidal anti-inflammatory drugs, glucocorticoids, and immunosuppressive agents are used for the treatment of IBD, while their clinical application is severely limited due to unwanted side effects. Chinese medicine (CM) is appealing more and more attention and investigation for the treatment of IBD owing to the potent anti-inflammation pharmacological efficacy and high acceptance by patients. In recent years, novel drug delivery systems are introduced apace to encapsulate CM and many CM-derived active constituents in order to improve solubility, stability and targeting ability. In this review, advanced drug delivery systems developed in the past and present to deliver CM for the treatment of IBD are summarized and future directions are discussed.
KW - Chinese medicine
KW - Drug delivery system
KW - Inflammatory bowel disease
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=85067572099&partnerID=8YFLogxK
U2 - 10.1186/s13020-019-0245-x
DO - 10.1186/s13020-019-0245-x
M3 - Review article
AN - SCOPUS:85067572099
SN - 1749-8546
VL - 14
JO - Chinese Medicine
JF - Chinese Medicine
IS - 1
M1 - 23
ER -